Search
Intuitive Surgical Inc
ISRGAdd to Watchlist
402.890USD
-3.890-0.96%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
142.71BMarket Cap
48.17P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.96%
5 Days
-3.28%
1 Month
-8.04%
6 Months
-30.52%
Year to Date
-28.86%
1 Year
-20.90%
Key Figures
401.330Open
408.535High
2.68MVolume
48.17P/E TTM
33.78P/E Dynamic
--Dividend TTM
0.76%Turnover Ratio
406.780Prev. Close
399.500Low
884.76MTurnover
61.48P/E Static
8.17P/B
0.00%Div Yield TTM
15.25%ROA
603.88052wk High
1.04Volume Ratio
2.32BNet Profit
354.40MShares
8.3634EPS TTM
1.65Beta
17.23%ROE
425.00052wk Low
2.22%Amplitude
66.06%Gross Margin
142.71BMarket Cap
-4.59Reward/Risk
1.64%Risk Rate
TradingKey Stock Score of Intuitive Surgical Inc
Currency: USD Updated: 2026-06-22Key Insights
Intuitive Surgical Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 34 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 570.92.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Intuitive Surgical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
38°C
Very Low
Very High
Negative
Intuitive Surgical Inc Highlights
StrengthsRisks
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 41.28% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 10.06B.
Undervalued
The company’s latest PE is 48.18, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 316.11M shares, decreasing 0.85% quarter-over-quarter.
Held by Frank Sands
Star Investor Frank Sands holds 1.46M shares of this stock.
Analyst Rating
Based on
34
analysts
Buy
Current Rating
570.921
Target Price
+40.35%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Intuitive Surgical Inc Info
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Ticker SymbolISRG
CompanyIntuitive Surgical Inc
CEORosa (David J)
Websitehttps://www.intuitive.com/en-us/about-us/company
Related Instruments
+1.42%
-0.07%
-0.72%
+3.03%
+0.63%
-1.01%
-0.09%
+1.65%
+0.45%
+0.98%
-2.15%
-0.17%
-1.69%
-3.42%
+0.07%
-2.91%
-2.27%
-0.46%
+0.77%Popular Instruments
73.385
-0.604 (-0.82%)
297.230
-0.780 (-0.26%)
208.780
-1.910 (-0.91%)
4129.010
-61.240 (-1.46%)
732.810
-13.420 (-1.80%)
2273.370
+88.620 (+4.06%)
1213.000
+79.010 (+6.97%)
349.710
-18.320 (-4.98%)
62478.000
-1925.800 (-2.99%)
404.920
+4.430 (+1.11%)
FAQs
What is the current price of Intuitive Surgical Inc (ISRG)?
The current price of Intuitive Surgical Inc (ISRG) is 402.89.
What is the symbol of Intuitive Surgical Inc?
The ticker symbol of Intuitive Surgical Inc is ISRG.
What is the 52-week high of Intuitive Surgical Inc?
The 52-week high of Intuitive Surgical Inc is 603.88.
What is the 52-week low of Intuitive Surgical Inc?
The 52-week low of Intuitive Surgical Inc is 425.00.
What is the market capitalization of Intuitive Surgical Inc?
The market capitalization of Intuitive Surgical Inc is 142.78B.
Is Intuitive Surgical Inc (ISRG) currently rated as Buy, Hold, or Sell?
According to analysts, Intuitive Surgical Inc (ISRG) has an overall rating of Buy, with a price target of 570.92.
What is the Earnings Per Share (EPS TTM) of Intuitive Surgical Inc (ISRG)?
The Earnings Per Share (EPS TTM) of Intuitive Surgical Inc (ISRG) is 8.00.
